Evidence map›Paper›PMID 38606726›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2024

Dermobile: A cost-effective portable device for erythema evaluation.

Sergio Del Río-Sancho, David Alvarez Martinez, Jöri Pünchera, Stéphane Guerrier, Hans Joachim Laubach

Open access · hybridAbstract readLetter
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sergio Del Río-SanchoLaser Dermatology Consultation, Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.ORCID https://orcid.org/0000-0001-9353-9504
David Alvarez MartinezLaser Dermatology Consultation, Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.
Jöri PüncheraLaser Dermatology Consultation, Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.
Stéphane GuerrierGSEM & Faculty of Science, University of Geneva, Geneva, Switzerland.
Hans Joachim LaubachLaser Dermatology Consultation, Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-6831-6517
University Hospital of Geneva · CHUniversity of Geneva · CH

Funding

Stratpharma Switzerland
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ErythemaCost-Benefit AnalysisEquipment DesignHumans

Identifiers

PMID38606726
PMCPMC11010262
OpenAlexW4394752256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.